We are expecting big things next year and hopefully things finally come into fruition. The recent raise unfortunately took us a step backwards in share price but ultimately has opened new opportunities. Our cash position is now strengthened which will gives us a good footing throughout 2020.
Additionally there are 500,000 options expiring in March with exercise of 35c and additional 1.1M in May at 30c.
On a side note: I recently joined a few diabetes Facebook support groups to conduct research on what people's sentiments are around Invokana and will also be asking for their opinions and thoughts on PromarkerD. Will report back what I find out.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)